Spectral Medical Statistics
Total Valuation
Spectral Medical has a market cap or net worth of 134.11 million. The enterprise value is 141.30 million.
Market Cap | 134.11M |
Enterprise Value | 141.30M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Spectral Medical has 280.38 million shares outstanding. The number of shares has increased by 0.33% in one year.
Shares Outstanding | 280.38M |
Shares Change (YoY) | +0.33% |
Shares Change (QoQ) | +0.32% |
Owned by Insiders (%) | 20.72% |
Owned by Institutions (%) | 13.02% |
Float | 191.51M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 77.25 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 81.39 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.36
Current Ratio | 0.36 |
Quick Ratio | 0.24 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.63 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -368.72% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | 59,862 |
Profits Per Employee | -622,241 |
Employee Count | 29 |
Asset Turnover | 0.30 |
Inventory Turnover | 17.86 |
Taxes
Income Tax | -1.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.29% in the last 52 weeks. The beta is 0.96, so Spectral Medical's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | +34.29% |
50-Day Moving Average | 0.48 |
200-Day Moving Average | 0.44 |
Relative Strength Index (RSI) | 40.27 |
Average Volume (20 Days) | 36,080 |
Short Selling Information
The latest short interest is 243,073, so 0.09% of the outstanding shares have been sold short.
Short Interest | 243,073 |
Short Previous Month | 241,186 |
Short % of Shares Out | 0.09% |
Short % of Float | 0.13% |
Short Ratio (days to cover) | 3.30 |
Income Statement
In the last 12 months, Spectral Medical had revenue of 1.74 million and -18.05 million in losses. Loss per share was -0.06.
Revenue | 1.74M |
Gross Profit | -1.83M |
Operating Income | -12.35M |
Pretax Income | -17.93M |
Net Income | -18.05M |
EBITDA | -12.07M |
EBIT | -12.35M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 2.07 million in cash and 9.26 million in debt, giving a net cash position of -7.19 million or -0.03 per share.
Cash & Cash Equivalents | 2.07M |
Total Debt | 9.26M |
Net Cash | -7.19M |
Net Cash Per Share | -0.03 |
Equity (Book Value) | -20.14M |
Book Value Per Share | -0.07 |
Working Capital | -6.90M |
Cash Flow
In the last 12 months, operating cash flow was -8.45 million and capital expenditures -201,000, giving a free cash flow of -8.65 million.
Operating Cash Flow | -8.45M |
Capital Expenditures | -201,000 |
Free Cash Flow | -8.65M |
FCF Per Share | -0.03 |
Margins
Gross margin is -105.13%, with operating and profit margins of -711.29% and -1,039.46%.
Gross Margin | -105.13% |
Operating Margin | -711.29% |
Pretax Margin | -1,032.89% |
Profit Margin | -1,039.46% |
EBITDA Margin | -695.05% |
EBIT Margin | -711.29% |
FCF Margin | -498.33% |
Dividends & Yields
Spectral Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.33% |
Shareholder Yield | -0.33% |
Earnings Yield | -13.46% |
FCF Yield | -6.45% |
Analyst Forecast
Price Target | 2.00 |
Price Target Difference | 316.67% |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |